This topic contains a solution. Click here to go to the answer

Author Question: The main reason for suboptimal drug levels in therapeutic drug monitoring is: A) Renal failure ... (Read 70 times)

waynest

  • Hero Member
  • *****
  • Posts: 553
The main reason for suboptimal drug levels in therapeutic drug monitoring is:
 
  A) Renal failure
  B) Liver failure
  C) Improper dosage prescribed
  D) Patient noncompliance with dosage regimen

Question 2

Bioavailability of a drug refers to the:
 
  A) Availability for therapeutic administration
  B) Availability of the protein-bound fraction of the drug
  C) Drug transformation
  D) Extent and rate at which the active drug reaches target tissues



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Ans: D

Answer to Question 2

Ans: D




waynest

  • Member
  • Posts: 553
Reply 2 on: Aug 10, 2018
Great answer, keep it coming :)


ecabral0

  • Member
  • Posts: 310
Reply 3 on: Yesterday
Excellent

 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library